Active-ingredient Dossier
Medroxyprogesterone Acetate
Active-ingredient Dossier for Medroxyprogesterone Acetate (progestin contraceptive). Australian brands, products, PBS listings, PBAC outcomes — compiled…
- Brand: DEPO-PROVERA
- Brand: PROVERA
- Brand: RALOVERA
- Brand: DEPO-RALOVERA
- Brand: DEPROCIP
- Brand: MEDPROCIP
- Therapeutic area: Reproductive Health
What is
Medroxyprogesterone Acetate Medroxyprogesterone Acetate is a progestin contraceptive.
Australian brands containing
Medroxyprogesterone Acetate — DEPO-PROVERA — PROVERA — RALOVERA — DEPO-RALOVERA — DEPROCIP — MEDPROCIP — SAYANA
Therapeutic areas
Medroxyprogesterone Acetate is registered in oncology (6 brands) and women's health (1 brand).
Sponsor landscape
The ingredient is marketed by Pfizer and Cipla.
PBS and regulatory activity
Three brands containing medroxyprogesterone acetate have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 November 2023, with one brand having a PBAC outcome on record and no brands with AusPARs on record.